Robert Delage

1.7k total citations
58 papers, 957 citations indexed

About

Robert Delage is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Robert Delage has authored 58 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 29 papers in Genetics and 10 papers in Rheumatology. Recurrent topics in Robert Delage's work include Chronic Lymphocytic Leukemia Research (22 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Acute Myeloid Leukemia Research (10 papers). Robert Delage is often cited by papers focused on Chronic Lymphocytic Leukemia Research (22 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Acute Myeloid Leukemia Research (10 papers). Robert Delage collaborates with scholars based in Canada, United States and France. Robert Delage's co-authors include Jean Roy, Félix Couture, Chantal Guillemette, Marie‐Odile Benoit‐Biancamano, Éric Lévesque, RJ Soiffer, Keith Dear, Jerome Ritz, Patrick Caron and C. Demers and has published in prestigious journals such as Blood, Cancer and Journal of Clinical Microbiology.

In The Last Decade

Robert Delage

54 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Delage Canada	18	400	305	205	178	141	58	957
Naohito Fujishima Japan	19	598 1.5×	232 0.8×	393 1.9×	326 1.8×	167 1.2×	63	1.4k
Mirco Belingheri Italy	17	199 0.5×	207 0.7×	423 2.1×	182 1.0×	89 0.6×	30	1.2k
Atsuo Maruta Japan	19	1.0k 2.5×	286 0.9×	107 0.5×	254 1.4×	217 1.5×	67	1.5k
Monzr M. Al Malki United States	18	761 1.9×	192 0.6×	313 1.5×	322 1.8×	178 1.3×	113	1.2k
Peter A.W. te Boekhorst Netherlands	21	582 1.5×	245 0.8×	113 0.6×	263 1.5×	221 1.6×	50	1.1k
Valérie Mialou France	12	407 1.0×	113 0.4×	190 0.9×	191 1.1×	228 1.6×	45	912
Karin Kolbe Germany	22	759 1.9×	146 0.5×	279 1.4×	465 2.6×	162 1.1×	53	1.2k
G. B. Vogelsang United States	17	963 2.4×	186 0.6×	405 2.0×	267 1.5×	106 0.8×	28	1.2k
Á Figuera Spain	17	545 1.4×	150 0.5×	92 0.4×	215 1.2×	48 0.3×	43	795
A Chaudhry Canada	15	503 1.3×	194 0.6×	117 0.6×	203 1.1×	85 0.6×	38	876

Countries citing papers authored by Robert Delage

Since Specialization

Citations

This map shows the geographic impact of Robert Delage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Delage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Delage more than expected).

Fields of papers citing papers by Robert Delage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Delage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Delage. The network helps show where Robert Delage may publish in the future.

Co-authorship network of co-authors of Robert Delage

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Delage. A scholar is included among the top collaborators of Robert Delage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Delage. Robert Delage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Delage, Robert, et al.. (2025). Low-level primary clarithromycin resistance of Helicobacter pylori in Reunion Island. Infectious Diseases Now. 55(2). 105025–105025. 1 indexed citations

Deschênes‐Simard, Xavier, Frédéric Barabé, Vinçent Laroche, et al.. (2024). Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study. Leukemia & lymphoma. 65(13). 1974–1982. 2 indexed citations

Dagenais-Bellefeuille, Steve, Karine Bilodeau, Shireen Sirhan, et al.. (2024). Understanding the Lived Experience of Fatigue in Adolescents and Young Adults with Myeloproliferative Neoplasms: A Mixed Methods Study. Blood. 144(Supplement 1). 408–408.

Garcia, Luciana Melo, et al.. (2022). CAR T-Cells for the Treatment of Refractory or Relapsed Large B-Cell Lymphoma: A Single-Center Retrospective Canadian Study. Clinical Lymphoma Myeloma & Leukemia. 23(3). 203–210. 4 indexed citations

Barabé, Frédéric, Vinçent Laroche, Geneviève Gallagher, et al.. (2022). Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study. Blood. 140(Supplement 1). 3304–3305. 1 indexed citations

Kim, Dennis Dong Hwan, Eshetu G. Atenafu, Igor Novitzky‐Basso, et al.. (2021). BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase. British Journal of Haematology. 196(1). 136–145. 4 indexed citations

Kim, Dennis Dong Hwan, Igor Novitzky‐Basso, Tae-Hyung Kim, et al.. (2020). Optimal Duration of Imatinib Treatment / Deep Molecular Response for Treatment-Free Remission after Imatinib Discontinuation from a Canadian Tyrosine Kinase Inhibitor Discontinuation Trial. Blood. 136(Supplement 1). 54–55. 3 indexed citations

Leitch, Heather A., Rena Buckstein, Nancy Zhu, et al.. (2018). Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS. Leukemia Research. 74. 21–41. 24 indexed citations

Kim, Dennis, Isabelle Bence‐Bruckler, Donna L. Forrest, et al.. (2017). Interim Results of the Canadian Tyrosine Kinase Inhibitor Discontinuation Trial for 2nd Attempt of Treatment Free Remission: Treatment Free Remission Accomplished By Dasatinib (TRAD). Blood. 130. 1622–1622. 7 indexed citations

10.

Schmitz, Norbert, Birte Friedrichs, Gustaaf W. van Imhoff, et al.. (2013). Hematopoietic Stem Cell Transplantation in Patients with Lymphomatoid Granulomatosis: A European Group for Blood and Marrow Transplantation Report. Biology of Blood and Marrow Transplantation. 19(10). 1522–1525. 12 indexed citations

11.

Lévesque, Éric, Marie‐Odile Benoit‐Biancamano, Robert Delage, Félix Couture, & Chantal Guillemette. (2008). Pharmacokinetics of Mycophenolate Mofetil and its Glucuronide Metabolites in Healthy Volunteers. Pharmacogenomics. 9(7). 869–879. 37 indexed citations

12.

Pollock, Carol A., David W. Johnson, Jérôme Rossert, et al.. (2008). Pure Red Cell Aplasia Induced by Erythropoiesis-Stimulating Agents. Clinical Journal of the American Society of Nephrology. 3(1). 193–199. 68 indexed citations

13.

Lévesque, Éric, Robert Delage, Marie‐Odile Benoit‐Biancamano, et al.. (2007). The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 81(3). 392–400. 134 indexed citations

14.

Robinson, Kelly, et al.. (2005). A Multicenter Randomized Trial Comparing Response-Adapted (RA), Non-Cross-Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantrone/Etoposide (NOVE) Compared with Consolidation with High Dose Cytarabine (HDAC) in Adult Patients with AML. A Study by the Canadian Leukemia Studies Group (CLSG).. Blood. 106(11). 4619–4619. 1 indexed citations

15.

Cournoyer, Denis, Edwin B. Toffelmire, George A. Wells, et al.. (2004). Anti-Erythropoietin Antibody-Mediated Pure Red Cell Aplasia after Treatment with Recombinant Erythropoietin Products. Journal of the American Society of Nephrology. 15(10). 2728–2734. 58 indexed citations

16.

Gilbert, Clare, Jean Roy, Robert Bélanger, et al.. (2001). Lack of Emergence of Cytomegalovirus UL97 Mutations Conferring Ganciclovir (GCV) Resistance following Preemptive GCV Therapy in Allogeneic Stem Cell Transplant Recipients. Antimicrobial Agents and Chemotherapy. 45(12). 3669–3671. 28 indexed citations

17.

Roy, Jean, Carle Ryckman, Vincent Bernier, Renaud Whittom, & Robert Delage. (1998). Large cell lymphoma complicating persistent polyclonal B cell lymphocytosis. Leukemia. 12(7). 1026–1030. 19 indexed citations

18.

Delage, Robert, C. Demers, Guy Cantin, & Jean Roy. (1996). Treatment of essential thrombocythemia during pregnancy with interferon-alpha.. PubMed. 87(5 Pt 2). 814–7. 39 indexed citations

19.

Anderson, KC, RJ Soiffer, Robert Delage, et al.. (1990). T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications. Blood. 76(1). 235–244. 41 indexed citations

20.

Ackermann, Hans-W., et al.. (1981). Un nouveau bactériophage d'entérobactéries à tête allongée et queue courte. Annales de l Institut Pasteur Virologie. 132(2). 229–234. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact